Bioneurema - Company finances
|
EUR
|
2022
From: 2022-08-25
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 50,544 | 25,629 | - |
| Profit before tax | -374 | 6,892 | -13,620 | -5,642 |
| Net profit | -374 | 6,623 | -13,620 | -5,642 |
| Equity | 2,626 | 9,248 | -4,371 | -10,012 |
| Liabilities | 154 | 1,404 | 4,633 | 10,103 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 2,780 | 10,652 | 262 | 91 |
| Total assets | 2,780 | 10,652 | 262 | 91 |
|
Taxes paid
|
||||
| STI taxes | - | 9,555 | 5,225 | 293 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | -49.3% | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -13.5% | 62.2% | -5198.5% | -6200.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -14.2% | 71.6% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 13.1% | -53.1% | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 13.6% | -53.1% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 50,544 | 25,629 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioneurema - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-01-23 | 2024-02-06 | 0.27 |
| 2023-12-18 | 2023-12-20 | 146.96 |
| 2023-11-17 | 2023-11-20 | 8.12 |
Bioneurema - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.